SEC Form 4 · accession 0000899243-17-026806
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel P Sears Jr.
Director
Period of report
Nov 15, 2017
Accepted (ET)
Nov 17, 2017 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 15, 2017 | S | 12,000 | $2.25 | D | 82,863 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of Issuer's Common Stock were sold pursuant to a pre-planned 10b5-1 plan to cover the Reporting Person's tax liability upon the vesting of RSUs in August 2017.
- F2On November 15, 2017, the Reporting Person sold an aggregate of 12,000 shares of the Issuer's Common Stock at a weighted average price of $2.25 per share. The highest sale price for the Common Stock was $2.35 per share and the lowest sale price was $2.15 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.